[Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
D001161:Arteriosclerosis / Q000150:complications; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced; D009127:Muscle Rigidity / Q000188:drug therapy; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D012075:Remission, Spontaneous; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013997:Time Factors; D014202:Tremor / Q000188:drug therapy
D004295:Dihydroxyphenylalanine
Trattamento della sindrome parkinsoniana con Levo-Dopa. Contributo casistico